Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

JFTH PHARMA : revenue, balance sheet and financial ratios

JFTH PHARMA is a French company , specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in ILLIES (59480), this company of category PME shows in 2025 a net income negative of -66 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - JFTH PHARMA (SIREN 941583528)
Indicator 2025
Revenue N/C
Net income -65 677 €
EBITDA -57 487 €
Net margin N/C

Revenue and income statement

In 2025, JFTH PHARMA records a net loss of 66 k€. This deficit will reduce equity on the balance sheet.

EBITDA (2025) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-57 487 €

EBIT (2025) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-57 487 €

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-65 677 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 2715%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 4%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

2714.585%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

3.553%

Repayment capacity (2025) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

-14.186

Solvency indicators evolution
JFTH PHARMA

Sector positioning

Debt ratio
2714.59 2025
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Watch

In 2025, the debt ratio of JFTH PHARMA (2714.59) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
3.55% 2025
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Watch

In 2025, the financial autonomy of JFTH PHARMA (3.5%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Repayment capacity
-14.19 years 2025
2025
Q1: 0.51 years
Med: 2.46 years
Q3: 6.25 years
Excellent

In 2025, the repayment capacity of JFTH PHARMA (-14.19) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

Interest coverage (2025) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-14.264

Liquidity indicators evolution
JFTH PHARMA

Sector positioning

Interest coverage
-14.26x 2025
2025
Q1: 0.0x
Med: 1.9x
Q3: 5.95x
Watch

In 2025, the interest coverage of JFTH PHARMA (-14.3x) ranks in the bottom 25% of the sector. This ratio indicates how many times operating income covers interest expenses. Low coverage may indicate fragility to rate or income variations.

Positioning of JFTH PHARMA in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare JFTH PHARMA with other companies in the same sector:

Frequently asked questions about JFTH PHARMA

What is the revenue of JFTH PHARMA ?

The revenue of JFTH PHARMA is not publicly disclosed (confidential accounts filed with INPI).

Is JFTH PHARMA profitable?

JFTH PHARMA recorded a net loss in 2025.

Where is the headquarters of JFTH PHARMA ?

The headquarters of JFTH PHARMA is located in ILLIES (59480), in the department Nord.

Where to find the tax return of JFTH PHARMA ?

The tax return of JFTH PHARMA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does JFTH PHARMA operate?

JFTH PHARMA operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.